Stop TB Partnership starts process for development of 2023-2030 Global Plan to End TB
Cover of the Global Plan to End TB 2018-2022
26 April 2021, Geneva, Switzerland - Stop TB Partnership today announces the start of the process to develop the next Global Plan to End Tuberculosis (TB). The new Global Plan will cover the period 2023 to 2030 and will specifically identify what resources are needed to end the TB epidemic globally. It will be developed through a year-long process of extensive and inclusive global and regional consultations, modelling and costing work focusing on the Sustainable Development Goal 3 (target of ending TB by 2030) and will align with the World Health Organization (WHO) End TB Strategy milestones.
A Task Force, consisting of members from mainly high TB burden countries and TB-affected communities with support from donors, private sector, multilateral development partners, researchers, and technical agencies, will lead the development of the Global Plan, including through consultative meetings with various regional and national stakeholders. Two worldwide web consultations will be conducted as part of the process, with the first one scheduled for May 2021 to identify priority areas that the Global Plan needs to focus on. Stop TB Partnership Working Groups on new diagnostics, new drugs, and new vaccines will contribute with their knowledge and expertise in the development and use of new tools during the period 2023 to 2030.
“This plan will take us to 2030, the year we are expected to end TB, as well as HIV and Malaria. If we believe in these targets, we must have plans that basically take us there – costed interventions, bold measures, all hands on deck, transparency, inclusiveness, equity for every single person that needs diagnosis, treatment and care for TB. Let us make it happen,” said Dr. Lucica Ditiu, Executive Director, Stop TB Partnership.
Since 2001, the Stop TB Partnership develops multi-year Global Plans for TB, which are costed plans that act as a roadmap for a concerted response to TB and based on WHO and UN strategic directions. Successive Global Plans have informed the Global Fund Investment Cases and have served as important advocacy and resource mobilization tools.